Evaluation of the Effectiveness of Health Literacy Education Given to Women by Teach-Back Method

NCT ID: NCT07320079

Last Updated: 2026-01-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

74 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-04-30

Study Completion Date

2027-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to enhance women's health literacy levels and to examine the effectiveness of the teach-back teaching technique in improving women's health literacy. The research was designed as a randomized controlled study. In addition, this study aims to answer the question of whether health literacy education delivered using the teach-back method is effective in improving women's health literacy levels. Within the scope of the study, participants in the experimental group will receive health literacy education using the teach-back technique, while the control group will receive standard care. Data will be collected using a questionnaire method.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aims to enhance women's health literacy levels and to examine the effectiveness of the teach-back teaching technique in improving women's health literacy. Women aged between 18 and 65 years with a General Health Questionnaire-12 score below 4 will be included in the study. To determine the participants' socio-demographic and health characteristics, the "Personal Information Form" will be used; to assess general health, the "General Health Questionnaire-12" will be applied; to measure health literacy levels, the "Türkiye Health Literacy Scale-32 (TSOY-32)" will be utilized; and to assess self-efficacy, the "General Self-Efficacy Scale" will be employed. Additionally, the "Training Effectiveness Evaluation Form" will be used to evaluate the effectiveness of the education provided to the experimental group. The study will consist of a total of 74 participants, with 37 in the experimental group and 37 in the control group. Verbal and written consent will be obtained from participants who agree to take part in the study, and the participants will be assigned to groups accordingly. The experimental group will receive face-to-face health literacy education using the teach-back method in six sessions, each lasting 45 minutes per week. The control group will receive standard care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Health Literacy Teach Back

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Experimental group and control group
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Teach-back

The experimental group will receive face-to-face health literacy education using the teach-back method in six sessions, each lasting 45 minutes per week.

The training will be provided by the researcher on a one-to-one basis. Health literacy education will be delivered using the teach-back method. After each session, participants will be asked to repeat what they have learned in their own words. The researcher will assess how well the participants have understood the topic. Any misunderstandings will be identified and corrected. During this process, participants will also have the opportunity to ask questions. Additional information will be provided if necessary until participants can accurately repeat the expected knowledge. The module will be considered complete once the participants have correctly expressed the information and understood the topic. The following week, the next module will begin, and this process will continue until all six modules are completed.

Group Type EXPERIMENTAL

teach-back

Intervention Type OTHER

The experimental group will receive face-to-face health literacy education using the teach-back method in six sessions, each lasting 45 minutes per week.

The training will be provided by the researcher on a one-to-one basis. Health literacy education will be delivered using the teach-back method. After each session, participants will be asked to repeat what they have learned in their own words. The researcher will assess how well the participants have understood the topic. Any misunderstandings will be identified and corrected. During this process, participants will also have the opportunity to ask questions. Additional information will be provided if necessary until participants can accurately repeat the expected knowledge. The module will be considered complete once the participants have correctly expressed the information and understood the topic. The following week, the next module will begin, and this process will continue until all six modules are completed.

Control Group

The control group will receive standard care.

Group Type OTHER

Control Group

Intervention Type OTHER

The control group will receive standard care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

teach-back

The experimental group will receive face-to-face health literacy education using the teach-back method in six sessions, each lasting 45 minutes per week.

The training will be provided by the researcher on a one-to-one basis. Health literacy education will be delivered using the teach-back method. After each session, participants will be asked to repeat what they have learned in their own words. The researcher will assess how well the participants have understood the topic. Any misunderstandings will be identified and corrected. During this process, participants will also have the opportunity to ask questions. Additional information will be provided if necessary until participants can accurately repeat the expected knowledge. The module will be considered complete once the participants have correctly expressed the information and understood the topic. The following week, the next module will begin, and this process will continue until all six modules are completed.

Intervention Type OTHER

Control Group

The control group will receive standard care

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women aged between 18 and 65 years
* Those with a General Health Questionnaire-12 score below 4

Exclusion Criteria

* Illiterate women
* Male individuals
* Those with communication difficulties
* Healthcare professionals (physicians, midwives, nurses, etc.)
* Emergency patients
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul University - Cerrahpasa

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Fatma Dünmez

PhD student

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Istanbul University- Cerrahpasa

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Fatma PhD student

Role: CONTACT

+90 (212) 866 37 00

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025-708

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.